Medical Cannabis Insurance Coverage Now Available to 45,000 Loblaw and Shoppers Drug Employees

Shoppers Drug Mart

Loblaw and its wholly owned subsidiary Shoppers Drug Mart, which is applying to Health Canada for a license to sell medical cannabis, have decided to include medical cannabis reimbursement in their employee benefits plans, according to the Toronto Star. With a combined 45,000 employees and an annual reimbursement of up to $1500 per employee, the companies could be on the hook for up to $67,500,00, though the actual amount will be dramatically lower, as the company will cover it for only a narrow range of conditions.

There have been only limited cases of insurance coverage in Canada to date, though we are monitoring another large potential transaction that we reported six months ago, with Mettrum selling a facility and license to Starseed, which was intending to sell medical cannabis to the 100K Canadian members of Laborers International Union of North America (LIUNA). Mettrum was subsequently sold to Canopy Growth (TSX: WEED) (OTC: TWMJF), and the deal is proceeding. Our understanding is that the labor union intends to provide the medical cannabis free of charge to its members who are authorized patients.

Large employers may find that reimbursing medical cannabis  for their employees is cost-effective and safer than other pharmaceuticals, especially in the treatment of pain. Germany is in the process of creating its federally legal medical cannabis program, and insurance coverage is a cornerstone of the plan, as well as being available in pharmacies.

Read Lisa Wright’s “Shoppers, Loblaw employees covered for medical marijuana”: https://www.thestar.com/business/2017/03/30/shoppers-loblaw-employees-covered-for-medical-marijuana.html

Get ahead of the crowd by signing up for 420 Investor, the largest & most comprehensive premium subscription service for cannabis traders and investors since 2013.

Published by Alan Brochstein, CFA
Alan Brochstein, CFA
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV. Contact Alan: Twitter | Facebook | LinkedIn | Email

Get Our Sunday Newsletter